This inventor holds 1 USPTO granted patent. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, University of Missouri. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3,697 
1 out of 899 
Years Active: 2024
Title: Chady Hakim: Innovator in CRISPR Therapy
Introduction
Chady Hakim is a prominent inventor based in Columbia, MO (US), known for his groundbreaking work in gene editing technologies. His innovative approach to CRISPR therapy has the potential to revolutionize the treatment of genetic conditions. With a focus on systemic gene editing, Hakim has made significant contributions to the field of biotechnology.
Latest Patents
Chady Hakim holds a patent for a dual-vector CRISPR-Cas therapy. This patent discloses methods for systemically editing a gene in a subject and for treating a genetic condition using a dual-vector system. The methods involve administering a gene editing AAV vector encoding a CRISPR effector protein and a targeting AAV vector providing one or more gRNAs targeted to the gene. The innovative aspect of this therapy is that the ratio of the targeting AAV vector to the gene editing vector is greater than or equal to 2. This patent represents a significant advancement in the field of gene therapy, with the potential to improve treatment outcomes for patients with genetic disorders. Chady Hakim has 1 patent to his name.
Career Highlights
Throughout his career, Chady Hakim has worked with esteemed institutions such as the University of Missouri and the National Institutes of Health, a component of the US Department of Health & Human Services. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical research.
Collaborations
Chady Hakim has collaborated with notable colleagues, including Dongsheng Duan and Nalinda B Wasala. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the realm of gene therapy.
Conclusion
Chady Hakim's contributions to CRISPR therapy exemplify the impact of innovative thinking in biotechnology. His work not only advances scientific knowledge but also holds promise for improving the lives of individuals with genetic conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile